Pseudo-peptide amyloid-β blocking inhibitors: molecular dynamics and single molecule force spectroscopy study

Area of Science:

• Biochemistry
• Biophysics
• Computational Biology

Background:

• Amyloid-beta (Aβ) aggregation is central to Alzheimer's disease pathogenesis.
• Blocking initial Aβ-Aβ binding is a therapeutic strategy to prevent toxic oligomer formation.

Purpose of the Study:

• To develop and test novel pseudo-peptide inhibitors targeting Aβ-Aβ binding.
• To validate computational methods for rational inhibitor design.

Main Methods:

• Molecular Dynamics (MD) simulations to analyze pseudo-peptide structures and binding.
• Umbrella Sampling calculations to estimate binding affinities.
• Atomic Force Spectroscopy (AFS) for experimental validation of inhibitor efficacy.

Main Results:

• MD simulations provided insights into pseudo-peptide binding characteristics with Aβ (13-23).
• AFS experiments confirmed that three designed pseudo-peptides effectively prevent Aβ-Aβ binding.
• Experimental and computational results showed good agreement.

Conclusions:

• The developed pseudo-peptides are effective inhibitors of Aβ-Aβ binding.
• This combined computational and experimental approach enables rational design of single-molecule inhibitors.
• These pseudo-peptides represent potential drug candidates for Alzheimer's disease treatment.